Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Cardiopulmonary Bypass Equipment Market Research Report 2026
Global Cardiopulmonary Bypass Equipment Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-07-11
Pages: 114 Pages
Report ld: 5528348
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cardiopulmonary Bypass Equipment Market Size(US$)
CAGR 2026-2032
9.7%
Market Size,2032
USD 1,042
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 598 million
Market Forecast in 2032(Value)
US$ 1,042 million
CAGR
9.7%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cardiopulmonary Bypass Equipment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cardiopulmonary Bypass Equipment refers to a life-support system designed to temporarily replace or assist the pumping function of the heart and the gas-exchange function of the lungs during open-heart and selected major vascular procedures. Its central component is generally a heart-lung machine, which removes venous blood from the patient, pumps it through an oxygenator for oxygenation and carbon-dioxide removal, and returns it to the arterial circulation. This process maintains systemic perfusion while the heart is stopped or blood flow is interrupted. A complete system typically includes roller or centrifugal pumps, a central control console, monitoring modules, heater-cooler units and gas-blending devices, operating together with disposable oxygenators, reservoirs, tubing sets, cannulae and filters. The equipment is primarily used in coronary artery bypass grafting, valve repair or replacement, congenital heart surgery, aortic procedures and cardiopulmonary transplantation. It must provide highly reliable control of blood flow, temperature, pressure, air detection, patient monitoring and procedural data.In 2025, global Cardiopulmonary Bypass Equipment production reached approximately 2000 units.The average gross profit margin of this product is 55%.
Population aging, the increasing prevalence of coronary and valvular heart disease, and the expansion of complex cardiac surgery into more regional medical centers are supporting sustained demand for cardiopulmonary bypass equipment. Although interventional and minimally invasive therapies are replacing surgery in selected patients, complex coronary lesions, multivalvular disease, congenital defects and major aortic disorders still require extracorporeal circulation. Hospitals are also replacing aging heart-lung machines and shifting purchasing priorities from basic pumping capability toward integrated monitoring, automated safety control and digital perfusion management. Embedded patient monitoring, advanced sensors and procedural data integration are extending product value from capital equipment into consumables, software, maintenance and clinical services.
Because cardiopulmonary bypass equipment directly supports blood circulation, failures involving pump speed, air management, temperature control or monitoring can have severe clinical consequences. Manufacturers must therefore complete extensive testing covering biocompatibility, mechanical integrity, blood damage, air entrapment, reliability and sterilization, while managing lengthy regulatory and hospital-approval processes. High acquisition costs, complex cardiac-surgery training requirements and shortages of qualified perfusion personnel can constrain adoption in smaller hospitals. Product recalls and component shortages may also damage customer confidence, making robust quality systems, preventive maintenance and responsive technical support essential competitive requirements.
Downstream purchasing is shifting from standalone heart-lung machines toward integrated combinations of equipment, disposables, clinical data and services. Major cardiac centers increasingly require real-time monitoring of flow, pressure, temperature, blood gases and reservoir levels, together with connectivity to hospital information systems. Pediatric cardiac programs place additional emphasis on low-prime circuits and precise flow control to reduce hemodilution and blood trauma. Standardized interfaces, automated warnings, electronic case documentation, remote diagnostics and clinical training are also becoming more important. Systems that simplify operation and improve consistency between perfusion teams are therefore likely to capture stronger replacement demand.
This report delivers a comprehensive overview of the global Cardiopulmonary Bypass Equipment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cardiopulmonary Bypass Equipment. The Cardiopulmonary Bypass Equipment market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cardiopulmonary Bypass Equipment market comprehensively. Regional market sizes by Type, by Application, by Surgical Procedure, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cardiopulmonary Bypass Equipment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Sorin Group
- LivaNova
- Medtronic
- Terumo Cardiovascular
- Fresenius Medical Care
- Getinge
- Braile Biomedica
- Chalice Medical
- Tianjin Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Single Roller Pump Cardiopulmonary Bypass Equipment
- Double Roller Pump Cardiopulmonary Bypass Equipment
Segment by Application
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
Segment by Category
- Cardiac Surgery
- Valve Surgery
- CABG Surgery
- Aortic Surgery
- Other
Segment by Division
- Cardiac Surgery Department
- Perfusion Department
- Hybrid OR
- Specialist Heart Center
- Other
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Surgical Procedure, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Cardiopulmonary Bypass Equipment manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Cardiopulmonary Bypass Equipment sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Cardiopulmonary Bypass Equipment Market Overview
1.1 Product Definition
1.2 Cardiopulmonary Bypass Equipment by Type
1.2.1 Global Cardiopulmonary Bypass Equipment Market Value by Type: 2025 vs 2032
1.2.2 Single Roller Pump Cardiopulmonary Bypass Equipment
1.2.3 Double Roller Pump Cardiopulmonary Bypass Equipment
1.3 Cardiopulmonary Bypass Equipment by Surgical Procedure
1.3.1 Global Cardiopulmonary Bypass Equipment Market Value by Surgical Procedure: 2025 vs 2032
1.3.2 Cardiac Surgery
1.3.3 Valve Surgery
1.3.4 CABG Surgery
1.3.5 Aortic Surgery
1.3.6 Other
1.4 Cardiopulmonary Bypass Equipment by Hospital Department
1.4.1 Global Cardiopulmonary Bypass Equipment Market Value by Hospital Department: 2025 vs 2032
1.4.2 Cardiac Surgery Department
1.4.3 Perfusion Department
1.4.4 Hybrid OR
1.4.5 Specialist Heart Center
1.4.6 Other
1.5 Cardiopulmonary Bypass Equipment by Application
1.5.1 Global Cardiopulmonary Bypass Equipment Market Value by Application: 2025 vs 2032
1.5.2 Cardiac Surgery
1.5.3 Lung Transplant Operation
1.5.4 Acute Respiratory Failure Treatment
1.5.5 Others
1.6 Global Cardiopulmonary Bypass Equipment Market Size Estimates and Forecasts
1.6.1 Global Cardiopulmonary Bypass Equipment Revenue 2021–2032
1.6.2 Global Cardiopulmonary Bypass Equipment Sales 2021–2032
1.6.3 Global Cardiopulmonary Bypass Equipment Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Cardiopulmonary Bypass Equipment Market Competition by Manufacturers
2.1 Global Cardiopulmonary Bypass Equipment Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cardiopulmonary Bypass Equipment Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cardiopulmonary Bypass Equipment, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Product Types and Applications
2.7 Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Date of Entry into the Industry
2.8 Global Cardiopulmonary Bypass Equipment Market Competitive Situation and Trends
2.8.1 Global Cardiopulmonary Bypass Equipment Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cardiopulmonary Bypass Equipment Players Market Share by Revenue
2.8.3 Global Cardiopulmonary Bypass Equipment Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiopulmonary Bypass Equipment Market Scenario by Region
3.1 Global Cardiopulmonary Bypass Equipment Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cardiopulmonary Bypass Equipment Sales by Region: 2021–2032
3.2.1 Global Cardiopulmonary Bypass Equipment Sales by Region: 2021–2026
3.2.2 Global Cardiopulmonary Bypass Equipment Sales by Region: 2027–2032
3.3 Global Cardiopulmonary Bypass Equipment Revenue by Region: 2021–2032
3.3.1 Global Cardiopulmonary Bypass Equipment Revenue by Region: 2021–2026
3.3.2 Global Cardiopulmonary Bypass Equipment Revenue by Region: 2027–2032
3.4 North America Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.4.3 North America Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.5.3 Europe Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Bypass Equipment Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiopulmonary Bypass Equipment Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cardiopulmonary Bypass Equipment Sales by Region (2021–2032)
3.6.3 Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.7.3 Latin America Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Bypass Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Bypass Equipment Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cardiopulmonary Bypass Equipment Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiopulmonary Bypass Equipment Sales by Type (2021–2032)
4.1.1 Global Cardiopulmonary Bypass Equipment Sales by Type (2021–2026)
4.1.2 Global Cardiopulmonary Bypass Equipment Sales by Type (2027–2032)
4.1.3 Global Cardiopulmonary Bypass Equipment Sales Market Share by Type (2021–2032)
4.2 Global Cardiopulmonary Bypass Equipment Revenue by Type (2021–2032)
4.2.1 Global Cardiopulmonary Bypass Equipment Revenue by Type (2021–2026)
4.2.2 Global Cardiopulmonary Bypass Equipment Revenue by Type (2027–2032)
4.2.3 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2021–2032)
4.3 Global Cardiopulmonary Bypass Equipment Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cardiopulmonary Bypass Equipment Sales by Application (2021–2032)
5.1.1 Global Cardiopulmonary Bypass Equipment Sales by Application (2021–2026)
5.1.2 Global Cardiopulmonary Bypass Equipment Sales by Application (2027–2032)
5.1.3 Global Cardiopulmonary Bypass Equipment Sales Market Share by Application (2021–2032)
5.2 Global Cardiopulmonary Bypass Equipment Revenue by Application (2021–2032)
5.2.1 Global Cardiopulmonary Bypass Equipment Revenue by Application (2021–2026)
5.2.2 Global Cardiopulmonary Bypass Equipment Revenue by Application (2027–2032)
5.2.3 Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2021–2032)
5.3 Global Cardiopulmonary Bypass Equipment Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sorin Group
6.1.1 Sorin Group Company Information
6.1.2 Sorin Group Description and Business Overview
6.1.3 Sorin Group Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sorin Group Cardiopulmonary Bypass Equipment Product Portfolio
6.1.5 Sorin Group Recent Developments/Updates
6.2 LivaNova
6.2.1 LivaNova Company Information
6.2.2 LivaNova Description and Business Overview
6.2.3 LivaNova Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 LivaNova Cardiopulmonary Bypass Equipment Product Portfolio
6.2.5 LivaNova Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Cardiopulmonary Bypass Equipment Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo Cardiovascular
6.4.1 Terumo Cardiovascular Company Information
6.4.2 Terumo Cardiovascular Description and Business Overview
6.4.3 Terumo Cardiovascular Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo Cardiovascular Cardiopulmonary Bypass Equipment Product Portfolio
6.4.5 Terumo Cardiovascular Recent Developments/Updates
6.5 Fresenius Medical Care
6.5.1 Fresenius Medical Care Company Information
6.5.2 Fresenius Medical Care Description and Business Overview
6.5.3 Fresenius Medical Care Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Medical Care Cardiopulmonary Bypass Equipment Product Portfolio
6.5.5 Fresenius Medical Care Recent Developments/Updates
6.6 Getinge
6.6.1 Getinge Company Information
6.6.2 Getinge Description and Business Overview
6.6.3 Getinge Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Getinge Cardiopulmonary Bypass Equipment Product Portfolio
6.6.5 Getinge Recent Developments/Updates
6.7 Braile Biomedica
6.7.1 Braile Biomedica Company Information
6.7.2 Braile Biomedica Description and Business Overview
6.7.3 Braile Biomedica Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Braile Biomedica Cardiopulmonary Bypass Equipment Product Portfolio
6.7.5 Braile Biomedica Recent Developments/Updates
6.8 Chalice Medical
6.8.1 Chalice Medical Company Information
6.8.2 Chalice Medical Description and Business Overview
6.8.3 Chalice Medical Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chalice Medical Cardiopulmonary Bypass Equipment Product Portfolio
6.8.5 Chalice Medical Recent Developments/Updates
6.9 Tianjin Medical
6.9.1 Tianjin Medical Company Information
6.9.2 Tianjin Medical Description and Business Overview
6.9.3 Tianjin Medical Cardiopulmonary Bypass Equipment Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Tianjin Medical Cardiopulmonary Bypass Equipment Product Portfolio
6.9.5 Tianjin Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Bypass Equipment Industry Chain Analysis
7.2 Cardiopulmonary Bypass Equipment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Bypass Equipment Production Mode & Process Analysis
7.4 Cardiopulmonary Bypass Equipment Sales and Marketing
7.4.1 Cardiopulmonary Bypass Equipment Sales Channels
7.4.2 Cardiopulmonary Bypass Equipment Distributors
7.5 Cardiopulmonary Bypass Equipment Customer Analysis
8 Cardiopulmonary Bypass Equipment Market Dynamics
8.1 Cardiopulmonary Bypass Equipment Industry Trends
8.2 Cardiopulmonary Bypass Equipment Market Drivers
8.3 Cardiopulmonary Bypass Equipment Market Challenges
8.4 Cardiopulmonary Bypass Equipment Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Cardiopulmonary Bypass Equipment Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cardiopulmonary Bypass Equipment Market Value by Surgical Procedure (US$ Million), 2025 vs 2032
Table 3. Global Cardiopulmonary Bypass Equipment Market Value by Hospital Department (US$ Million), 2025 vs 2032
Table 4. Global Cardiopulmonary Bypass Equipment Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Cardiopulmonary Bypass Equipment Market Competitive Situation by Manufacturers in 2025
Table 6. Global Cardiopulmonary Bypass Equipment Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Cardiopulmonary Bypass Equipment Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Cardiopulmonary Bypass Equipment Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Cardiopulmonary Bypass Equipment Average Price (K USD/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Cardiopulmonary Bypass Equipment, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Product Types and Applications
Table 14. Global Key Manufacturers of Cardiopulmonary Bypass Equipment, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Cardiopulmonary Bypass Equipment Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cardiopulmonary Bypass Equipment Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Cardiopulmonary Bypass Equipment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Cardiopulmonary Bypass Equipment Sales by Region (Units), 2021–2026
Table 20. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2021–2026)
Table 21. Global Cardiopulmonary Bypass Equipment Sales by Region (Units), 2027–2032
Table 22. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2027–2032)
Table 23. Global Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2021–2026
Table 24. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2021–2026)
Table 25. Global Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2027–2032
Table 26. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2027–2032)
Table 27. North America Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
Table 29. North America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
Table 30. North America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
Table 31. North America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
Table 34. Europe Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
Table 35. Europe Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Cardiopulmonary Bypass Equipment Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Cardiopulmonary Bypass Equipment Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Cardiopulmonary Bypass Equipment Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
Table 44. Latin America Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
Table 45. Latin America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Cardiopulmonary Bypass Equipment Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Cardiopulmonary Bypass Equipment Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue by Country (US$ Million), 2027–2032
Table 52. Global Cardiopulmonary Bypass Equipment Sales (Units) by Type (2021–2026)
Table 53. Global Cardiopulmonary Bypass Equipment Sales (Units) by Type (2027–2032)
Table 54. Global Cardiopulmonary Bypass Equipment Sales Market Share by Type (2021–2026)
Table 55. Global Cardiopulmonary Bypass Equipment Sales Market Share by Type (2027–2032)
Table 56. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2021–2026)
Table 59. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2027–2032)
Table 60. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Type (2021–2026)
Table 61. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Type (2027–2032)
Table 62. Global Cardiopulmonary Bypass Equipment Sales (Units) by Application (2021–2026)
Table 63. Global Cardiopulmonary Bypass Equipment Sales (Units) by Application (2027–2032)
Table 64. Global Cardiopulmonary Bypass Equipment Sales Market Share by Application (2021–2026)
Table 65. Global Cardiopulmonary Bypass Equipment Sales Market Share by Application (2027–2032)
Table 66. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Cardiopulmonary Bypass Equipment Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2021–2026)
Table 69. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2027–2032)
Table 70. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Application (2021–2026)
Table 71. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Application (2027–2032)
Table 72. Sorin Group Company Information
Table 73. Sorin Group Description and Business Overview
Table 74. Sorin Group Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 75. Sorin Group Cardiopulmonary Bypass Equipment Product
Table 76. Sorin Group Recent Developments/Updates
Table 77. LivaNova Company Information
Table 78. LivaNova Description and Business Overview
Table 79. LivaNova Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 80. LivaNova Cardiopulmonary Bypass Equipment Product
Table 81. LivaNova Recent Developments/Updates
Table 82. Medtronic Company Information
Table 83. Medtronic Description and Business Overview
Table 84. Medtronic Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 85. Medtronic Cardiopulmonary Bypass Equipment Product
Table 86. Medtronic Recent Developments/Updates
Table 87. Terumo Cardiovascular Company Information
Table 88. Terumo Cardiovascular Description and Business Overview
Table 89. Terumo Cardiovascular Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 90. Terumo Cardiovascular Cardiopulmonary Bypass Equipment Product
Table 91. Terumo Cardiovascular Recent Developments/Updates
Table 92. Fresenius Medical Care Company Information
Table 93. Fresenius Medical Care Description and Business Overview
Table 94. Fresenius Medical Care Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 95. Fresenius Medical Care Cardiopulmonary Bypass Equipment Product
Table 96. Fresenius Medical Care Recent Developments/Updates
Table 97. Getinge Company Information
Table 98. Getinge Description and Business Overview
Table 99. Getinge Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 100. Getinge Cardiopulmonary Bypass Equipment Product
Table 101. Getinge Recent Developments/Updates
Table 102. Braile Biomedica Company Information
Table 103. Braile Biomedica Description and Business Overview
Table 104. Braile Biomedica Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 105. Braile Biomedica Cardiopulmonary Bypass Equipment Product
Table 106. Braile Biomedica Recent Developments/Updates
Table 107. Chalice Medical Company Information
Table 108. Chalice Medical Description and Business Overview
Table 109. Chalice Medical Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 110. Chalice Medical Cardiopulmonary Bypass Equipment Product
Table 111. Chalice Medical Recent Developments/Updates
Table 112. Tianjin Medical Company Information
Table 113. Tianjin Medical Description and Business Overview
Table 114. Tianjin Medical Cardiopulmonary Bypass Equipment Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 115. Tianjin Medical Cardiopulmonary Bypass Equipment Product
Table 116. Tianjin Medical Recent Developments/Updates
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Cardiopulmonary Bypass Equipment Distributors List
Table 120. Cardiopulmonary Bypass Equipment Customers List
Table 121. Cardiopulmonary Bypass Equipment Market Trends
Table 122. Cardiopulmonary Bypass Equipment Market Drivers
Table 123. Cardiopulmonary Bypass Equipment Market Challenges
Table 124. Cardiopulmonary Bypass Equipment Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cardiopulmonary Bypass Equipment
Figure 2. Global Cardiopulmonary Bypass Equipment Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cardiopulmonary Bypass Equipment Market Share by Type: 2025 & 2032
Figure 4. Single Roller Pump Cardiopulmonary Bypass Equipment Product Picture
Figure 5. Double Roller Pump Cardiopulmonary Bypass Equipment Product Picture
Figure 6. Global Cardiopulmonary Bypass Equipment Market Value by Surgical Procedure (US$ Million), 2021–2032
Figure 7. Global Cardiopulmonary Bypass Equipment Market Share by Surgical Procedure: 2025 vs 2032
Figure 8. Cardiac Surgery Product Picture
Figure 9. Valve Surgery Product Picture
Figure 10. CABG Surgery Product Picture
Figure 11. Aortic Surgery Product Picture
Figure 12. Other Product Picture
Figure 13. Global Cardiopulmonary Bypass Equipment Market Value by Hospital Department (US$ Million), 2021–2032
Figure 14. Global Cardiopulmonary Bypass Equipment Market Share by Hospital Department: 2025 vs 2032
Figure 15. Cardiac Surgery Department Product Picture
Figure 16. Perfusion Department Product Picture
Figure 17. Hybrid OR Product Picture
Figure 18. Specialist Heart Center Product Picture
Figure 19. Other Product Picture
Figure 20. Global Cardiopulmonary Bypass Equipment Market Value by Application (US$ Million), 2021–2032
Figure 21. Global Cardiopulmonary Bypass Equipment Market Share by Application: 2025 & 2032
Figure 22. Cardiac Surgery
Figure 23. Lung Transplant Operation
Figure 24. Acute Respiratory Failure Treatment
Figure 25. Others
Figure 26. Global Cardiopulmonary Bypass Equipment Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Cardiopulmonary Bypass Equipment Market Size (US$ Million), 2021–2032
Figure 28. Global Cardiopulmonary Bypass Equipment Sales (Units), 2021–2032
Figure 29. Global Cardiopulmonary Bypass Equipment Average Price (K USD/Unit), 2021–2032
Figure 30. Cardiopulmonary Bypass Equipment Report Years Considered
Figure 31. Cardiopulmonary Bypass Equipment Sales Share by Manufacturers in 2025
Figure 32. Global Cardiopulmonary Bypass Equipment Revenue Share by Manufacturers in 2025
Figure 33. Top 5 and Top 10 Global Cardiopulmonary Bypass Equipment Players: Market Share by Revenue in Cardiopulmonary Bypass Equipment in 2025
Figure 34. Cardiopulmonary Bypass Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 35. Global Cardiopulmonary Bypass Equipment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 36. North America Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
Figure 37. North America Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
Figure 38. U.S. Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Canada Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Europe Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
Figure 41. Europe Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
Figure 42. Germany Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. France Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. U.K. Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Italy Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Russia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Asia Pacific Cardiopulmonary Bypass Equipment Sales Market Share by Region (2021–2032)
Figure 48. Asia Pacific Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2021–2032)
Figure 49. China Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Japan Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. South Korea Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. India Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Australia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. China Taiwan Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Indonesia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Thailand Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Malaysia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Latin America Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
Figure 59. Latin America Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
Figure 60. Mexico Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Brazil Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Argentina Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Middle East and Africa Cardiopulmonary Bypass Equipment Sales Market Share by Country (2021–2032)
Figure 64. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue Market Share by Country (2021–2032)
Figure 65. Turkey Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 66. Saudi Arabia Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 67. UAE Cardiopulmonary Bypass Equipment Revenue Growth Rate (US$ Million), 2021–2032
Figure 68. Global Sales Market Share of Cardiopulmonary Bypass Equipment by Type (2021–2032)
Figure 69. Global Revenue Market Share of Cardiopulmonary Bypass Equipment by Type (2021–2032)
Figure 70. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Type (2021–2032)
Figure 71. Global Sales Market Share of Cardiopulmonary Bypass Equipment by Application (2021–2032)
Figure 72. Global Revenue Market Share of Cardiopulmonary Bypass Equipment by Application (2021–2032)
Figure 73. Global Cardiopulmonary Bypass Equipment Price (K USD/Unit) by Application (2021–2032)
Figure 74. Cardiopulmonary Bypass Equipment Value Chain
Figure 75. Channels of Distribution (Direct Vs Distribution)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Cardiopulmonary Bypass Equipment in 2026?
The global market size of Cardiopulmonary Bypass Equipment in 2026 was 598 Million USD.
Which companies rank high in the global Cardiopulmonary Bypass Equipment market?
Which region is expected to have the highest market share?
What was the global market size of Cardiopulmonary Bypass Equipment in 2032?
What is the annual compound growth rate of the global Cardiopulmonary Bypass Equipment market size from 2026 to 2032?
Related Reports
Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 139
USD 4900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiopulmonary Bypass Equipment market size was US$ 550 million in 2025 and is forecast to reach a readjusted size of US$ 1042 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published Date: 2026-07-11
Pages: 128
USD 4250.00
(Single User License)
Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 132
USD 3950.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 506 million in 2024 to US$ 959 million by 2031, at a CAGR of 9.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 135
USD 4900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 123
USD 5900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 77
USD 4250.00
(Single User License)
Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 109
USD 3950.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Research Report 2025
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-01-16
Pages: 83
USD 2900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published Date: 2024-04-17
Pages: 146
USD 5600.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published Date: 2024-04-16
Pages: 123
USD 5900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 139
USD 4900.00 (Single User License)Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiopulmonary Bypass Equipment market size was US$ 550 million in 2025 and is forecast to reach a readjusted size of US$ 1042 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published: 2026-07-11
Pages: 128
USD 4250.00 (Single User License)Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-07-11
Pages: 132
USD 3950.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 506 million in 2024 to US$ 959 million by 2031, at a CAGR of 9.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 135
USD 4900.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 123
USD 5900.00 (Single User License)Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 77
USD 4250.00 (Single User License)Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 109
USD 3950.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Research Report 2025
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-01-16
Pages: 83
USD 2900.00 (Single User License)Global Cardiopulmonary Bypass Equipment Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published: 2024-04-17
Pages: 146
USD 5600.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published: 2024-04-16
Pages: 123
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now